Our study showed that patients with medical cannabis authorization have a higher risk of emergency department visits or hospitalizations for depression compared to patients with no authorization. Our results also suggest that this risk is increased among patients without prior mental health disorders at cannabis authorization. The findings emphasize the need for a careful risk-benefit assessment that takes into account this observation prior to cannabis authorization. Further longitudinal